These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23189754)

  • 1. Individualized care for improved outcomes in patients with atrial fibrillation.
    Winston SA
    J Am Osteopath Assoc; 2012 Sep; 112(9 Suppl 2):Sii-Siii. PubMed ID: 23189754
    [No Abstract]   [Full Text] [Related]  

  • 2. A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillation.
    Ciervo CA; Granger CB; Schaller FA; Engelke KA
    J Am Osteopath Assoc; 2012 Sep; 112(9 Suppl 2):eS9-21. PubMed ID: 23014815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

  • 4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 5. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 6. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bad medicine: atrial fibrillation.
    Spence D
    BMJ; 2013 Aug; 347():f4910. PubMed ID: 23924656
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 10. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Hart RG
    Adv Neurol; 2003; 92():249-56. PubMed ID: 12760190
    [No Abstract]   [Full Text] [Related]  

  • 12. Stroke prevention in patients with atrial fibrillation: disease burden and unmet medical needs.
    Ciervo CA; Granger CB; Schaller FA
    J Am Osteopath Assoc; 2012 Sep; 112(9 Suppl 2):eS2-8. PubMed ID: 23014814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.
    Olshansky B; Guo H
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):571-90. PubMed ID: 16076269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
    Nieuwlaat R; Connolly SJ
    Heart; 2009 Feb; 95(2):95-7. PubMed ID: 18952632
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation control in atrial fibrillation: optimizing risks and benefits.
    Alsheikh-Ali AA; Estes NA
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):72-3. PubMed ID: 20031792
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
    Lip GY
    Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
    [No Abstract]   [Full Text] [Related]  

  • 20. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.